ArticleBMC infectious diseases2025
Differences found in patient characteristics of migrant tuberculosis sub-populations within low TB incidence European countries, 2014-2020.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- National Inpatient Burden, Treatment Patterns, and In-Hospital Mortality of Spinal Tuberculosis in Germany Amid Demographic Change: A Population-Based DRG Study, 2019-2025.Global spine journal · 2026Article
- Multidrug-Resistant Tuberculosis in Rural Eastern Cape, South Africa: Clinical, Bacteriological, and Programmatic Predictors of Poor Treatment Outcomes.Microorganisms · 2026Article
- Diagnostic algorithms for tuberculosis in Europe: insights from the European Reference Laboratory Network for Tuberculosis (ERLTB-Net).The Lancet regional health. Europe · 2026Review
- Article
- Authors' response: Migrant tuberculosis in low-incidence Japan; introduction of pre-entry screening.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionIn low TB incidence countries, prevention and care activities addressing migrant populations are essential for TB control. Understanding characteristics of TB patients in the migrant population is important for planning and providing appropriate care. This study aims to inform prevention and care strategies by describing characteristics of TB patients within migrant subpopulations in Europe to understand whether differences exist in their patient profiles.
methodsThis cross-sectional descriptive study of migrants with TB reported to the European Surveillance System (2014-2020) from 23 low incidence European countries describes characteristics of different subgroups, according to TB epidemiological indicators and interval between arrival and notification.
resultsMigrants with TB originating from very high TB incidence countries had the highest proportion of people living with HIV (7%) and highest extrapulmonary TB proportion (44%). Patients from high incidence countries had the highest proportion with previous TB diagnosis (14%), first line (12%) and multidrug (6%) resistances. Compared to all patients, patients arriving from the 10 countries with the highest crude incidence rates were on average 9 years younger (median age 25 vs 34) and more often male (M:F ratio 2.6 vs. 1.8). Patients notified < 2 years after arrival had higher proportions diagnosed with PTB (67%) and MDR-TB (4%), as well as people living with HIV (7%). DISCUSSION: Unique patterns in patient characteristics were observed which varied by origin and destination. Improving European TB preparedness within the context of migration requires timely and complete international data alongside continuous access to quality TB care, not only at entry, and expanded opportunities for diagnosis given levels of extrapulmonary TB observed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.